Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Pediatr Blood Cancer. 2009 Feb;52(2):169–176. doi: 10.1002/pbc.21873

Table III.

Frequency of Grade 3 or 4 Adverse Events (Number of Patients) Attributed to SU5416 Observed in All Eligible Patients (n=33).

Stratum I Stratum II
Course 1 Course 2–10 Course 1 Course 2–10
Lymphopenia 1 (1) 7 (1)
Allergic reaction/Hypersensitivity 1 (1)
SGOT (AST) 2 (2)
SGPT (ALT) 1 (1) 1 (1)
Hypophosphatemia 3 (2)
Hallucinations 1 (1)
Arthralgia (joint pain) 1 (1) 1 (1)
Headache 1 (1) 3 (2)
Rash 1 (1)